Investment KPCB Leads $30M Series B Round In Chinese 3D Printing Service Provider August 8, 2019 — 17:42
Interviews KPCB’s James Huang Says High Healthcare Valuations Force Investors To Seek Early Stage Innovation October 18, 2017 — 14:21
Exits Chinese Biopharma Firm Zai Lab Completes $150M US Listing, Shares Jump 55% September 21, 2017 — 12:20
